AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitafirst M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Akned Healthcare Pvt. Ltd.

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitafirst M 50mg/500mg Tablet

Diabetol Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in type 2 diabetes. This dual action helps prevent severe diabetic complications like renal failure and vision loss, and may lessen the risk of cardiovascular events. Diabetol Duo 50mg/500mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle choices significantly impact glycemic control. Common side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for everyone. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals must consult their doctor. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Uses of Sitafirst M 50mg/500mg Tablet

Treatment of Type 2 diabetes mellitus

Major Benefits of Sitafirst M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitafirst M 50mg/500mg tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Sitafirst M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitafirst M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitafirst M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with meals.

How Sitafirst M 50mg/500mg Tablet works:

Sitafirst M 50mg/500mg Tablet is a combination of two medicines: sitagliptin and metformin. Sitagliptin help your pancreas produce more insulin, facilitate effective use of insulin by the body, and reduce excess sugar that your liver makes. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Together, they provide better control of blood sugar.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitafirst M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitafirst M 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitafirst M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Operating a vehicle could be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitafirst M 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician. Sitafirst M 50mg/500mg Tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitafirst M 50mg/500mg tablets is potentially hazardous for individuals with hepatic impairment and is best avoided. Medical advice is recommended.

What if you forget to take Sitafirst M 50mg/500mg Tablet :

If you miss a dose of Sitafirst M 50mg/500mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Facts to Know About Sitafirst M 50mg/500mg Tablet

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Sitafirst M 50mg/500mg Tablet

Sitagliptin and Metformin 50mg/500mg tablets (Sitafirst M) manage type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when combined with a balanced diet and physical activity. Metformin reduces hepatic glucose production and boosts insulin sensitivity, while Sitagliptin inhibits DPP-4, thereby promoting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitafirst M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This medication impairs the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia and neurological complications, manifesting as tingling or numbness in the extremities, muscle weakness, urinary issues, cognitive changes, and impaired coordination. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some studies.
Sitafirst M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis can occur. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitafirst M 50mg/500mg Tablet constituent should not use this medication. Similarly, its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitafirst M 50mg/500mg Tablet with alcohol is unsafe due to the heightened risk of lactic acidosis.
Retain this medication in its original, tightly sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal pain, or bradycardia warrant immediate discontinuation of Sitagliptin/Metformin and prompt medical attention.
Sitafirst M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication helps regulate blood sugar when coupled with a healthy diet and exercise regimen. Metformin reduces hepatic glucose production and enhances insulin sensitivity, while sitagliptin's DPP4 inhibition boosts pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitafirst M 50mg/500mg Tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitafirst M 50mg/500mg Tablet constituent or additive should not use this medication. Its administration is contraindicated in individuals with significant renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitafirst M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition resulting from excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates avoidance in individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Sitagliptin/Metformin and prompt medical attention.
Prolonged use of Sitafirst M 50mg/500mg Tablets can indeed lead to vitamin B12 deficiency. This medication impairs the stomach's absorption of vitamin B12. Consequently, untreated deficiency may manifest as anemia, neurological issues—including tingling, numbness in the extremities, weakness, urinary dysfunction, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some studies.
Store this medication in its original, tightly sealed container, following the storage instructions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitafirst M 50mg/500mg tablets contain sitagliptin and metformin, two medications used together to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and enhances insulin responsiveness. Sitagliptin works by suppressing DPP4, thereby boosting insulin secretion from the pancreas. This medication is unsuitable for individuals under 18.
Sitafirst M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitafirst M 50mg/500mg Tablet ingredient or inactive component should not take this medication. Its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitafirst M 50mg/500mg Tablet is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitafirst M 50mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this uncommon side effect of metformin necessitates avoidance in individuals with pre-existing kidney problems, the elderly, or those who consume substantial alcohol. Lactic acidosis symptoms can manifest as muscular discomfort or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, queasiness, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitafirst M 50mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications. Symptoms can include paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, as proposed by some studies, involve supplemental Vitamin B12 administration at least annually.
Store this medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Sitafirst M 50mg/500mg Ta...
164
MRP 190
13% off